{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Streptococcus+pneumoniae+vaccine&page=5", "query": { "intervention": "Streptococcus pneumoniae vaccine", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 260, "total_pages": 26, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Streptococcus+pneumoniae+vaccine&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Streptococcus+pneumoniae+vaccine&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T14:06:15.284Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06156228", "title": "Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vaccine Hesitancy" ], "interventions": [ { "name": "Multilevel Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "San Diego State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 238, "start_date": "2024-03-06", "completion_date": "2025-04-01", "has_results": false, "last_update_posted_date": "2025-07-04", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 2, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06156228" }, { "nct_id": "NCT00422292", "title": "Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, Rubella and Varicella", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "9 Months to 12 Months" }, "enrollment_count": 1664, "start_date": "2006-12", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 87, "location_summary": "Tuscaloosa, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 74 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Atascadero", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00422292" }, { "nct_id": "NCT05095844", "title": "National Vaccine Adverse Event Reporting Survey and Etiology", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID-19", "Vaccine Adverse Reaction", "Vaccine Reaction", "Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use", "Corona Virus Infection", "Blood Clot", "Thrombocytopenia", "Neuritis", "Vasculitis", "Influenza", "Guillain-Barré", "GWAS", "Genetic Sequencing" ], "interventions": [ { "name": "vaccinated", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Neuroganics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "5 Years to 99 Years" }, "enrollment_count": 100000, "start_date": "2022-03-15", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 1, "location_summary": "Northglenn, Colorado", "locations": [ { "city": "Northglenn", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05095844" }, { "nct_id": "NCT06740630", "title": "A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chickenpox" ], "interventions": [ { "name": "Investigational varicella vaccine_Lot 1", "type": "BIOLOGICAL" }, { "name": "Investigational varicella vaccine_Lot 2", "type": "BIOLOGICAL" }, { "name": "Investigational varicella vaccine_Lot 3", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine_Lot 1", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine_Lot 2", "type": "BIOLOGICAL" }, { "name": "MMR vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" }, { "name": "PCV (pneumococcal conjugate vaccine) 13", "type": "BIOLOGICAL" }, { "name": "PCV 20", "type": "BIOLOGICAL" }, { "name": "Vaxneuvance", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 1840, "start_date": "2025-01-10", "completion_date": "2027-05-17", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 59, "location_summary": "Mobile, Alabama • Hot Springs, Arkansas • Sherwood, Arkansas + 50 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Sherwood", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06740630" }, { "nct_id": "NCT04887948", "title": "Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Disease", "COVID-19", "SARS-CoV-2 Infection" ], "interventions": [ { "name": "20-valent pneumococcal conjugate vaccine (20vPnC)", "type": "BIOLOGICAL" }, { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 570, "start_date": "2021-05-20", "completion_date": "2021-12-08", "has_results": true, "last_update_posted_date": "2022-12-14", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 27, "location_summary": "Anaheim, California • Walnut Creek, California • Coral Gables, Florida + 21 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04887948" }, { "nct_id": "NCT00294021", "title": "Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pneumococcal Infections" ], "interventions": [], "intervention_types": [], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2006-03", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2012-09-26", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 1, "location_summary": "Chinle, Fort Defiance, Whiteriver, AZ; Gallup, Shiprock, NM, Arizona", "locations": [ { "city": "Chinle, Fort Defiance, Whiteriver, AZ; Gallup, Shiprock, NM", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00294021" }, { "nct_id": "NCT04379713", "title": "20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "20-valent pneumococcal conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "13-valent pneumococcal conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "98 Days", "sex": "ALL", "summary": "42 Days to 98 Days" }, "enrollment_count": 1511, "start_date": "2020-05-21", "completion_date": "2022-08-31", "has_results": true, "last_update_posted_date": "2023-06-13", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 41, "location_summary": "Tucson, Arizona • Fullerton, California • Oxnard, California + 33 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04379713" }, { "nct_id": "NCT06531538", "title": "A Study to Learn About How a New Pneumococcal Vaccine Works in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "PG4", "type": "BIOLOGICAL" }, { "name": "20-valent pneumococcal conjugate vaccine (20vPnC)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 225, "start_date": "2024-07-30", "completion_date": "2026-02-09", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 35, "location_summary": "Washington D.C., District of Columbia • Miami, Florida • Chamblee, Georgia + 18 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Chamblee", "state": "Georgia" }, { "city": "Fayetteville", "state": "Georgia" }, { "city": "Union City", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06531538" }, { "nct_id": "NCT06855160", "title": "A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chickenpox" ], "interventions": [ { "name": "Candidate varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine", "type": "BIOLOGICAL" }, { "name": "MMR vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" }, { "name": "PCV (pneumococcal conjugate vaccine) 13", "type": "BIOLOGICAL" }, { "name": "PCV 20", "type": "BIOLOGICAL" }, { "name": "Vaxneuvance", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 911, "start_date": "2025-04-17", "completion_date": "2027-02-02", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 13, "location_summary": "Tucson, Arizona • Huntington Park, California • Sherman Oaks, California + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Park", "state": "California" }, { "city": "Sherman Oaks", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06855160" }, { "nct_id": "NCT00002392", "title": "A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Thalidomide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rockefeller University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-08T14:06:15.284Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002392" } ] }